berdazimer topical (Pending FDA Approval)

Brand and Other Names:
Sections

Dosing & Uses

Molluscum Contagiosum

Pending FDA approval for treatment of molluscum contagiosum

Next:

Pharmacology

Mechanism of Action

Topical nitric oxide (NO)-releasing product consisting of berdazimer and a carboxymethyl cellulose hydrogel that acts as a proton donor

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.